SCHEMBL213905

SCHEMBL213905

CCCC(C)=NOC(C)=O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 4/20 0.42
HDAC1 Q13547 4/20 0.42
HDAC2 Q92769 4/20 0.42
HDAC8 Q9BY41 4/20 0.42
HDAC6 Q9UBN7 1/20 0.42
ALDH1A1 P00352 3/20 0.39
CES1 P23141 2/20 0.38
CES2 O00748 1/20 0.38
FFAR3 O14843 3/20 0.36
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HSP90AA1 P07900 1/20 0.32
PKM P14618 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CTSD P07339 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL213904 1.00 HDAC3 (0.42) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL2050853 0.87 ALDH1A1 (0.36) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL2050851 0.87 ALDH1A1 (0.36) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL212903 0.86 CES1 (0.43) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL212904 0.86 CES1 (0.43) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL18840170 0.86 CES1 (0.43) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL214866 0.85 HSP90AA1 (0.47) ALDH1A1CES1CES2TSHRHSD17B10
SCHEMBL214867 0.85 HSP90AA1 (0.47) ALDH1A1CES1CES2TSHRHSD17B10
SCHEMBL213415 0.83 ALDH1A1 (0.40) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL214861 0.83 HSP90AA1 (0.50) ALDH1A1CES1CES2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077941-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS BRIDGESTONE CORPORATION (JP) 2012-03-29 US claimed
US-8088868-B2 oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis BRIDGESTONE CORPORATION (JP) 2012-01-03 US claimed
US-20080146745-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS BRIDGESTONE CORPORATION (JP) 2008-06-19 US claimed
CN-109415573-A Composition, film, optical filter, laminated body, solid-state imaging element, image display device, infrared sensor and compound 富士胶片株式会社 2019-03-01 CN disclosed
US-8541509-B2 Polymers functionalized with protected oxime compounds BRIDGESTONE CORPORATION (JP) 2013-09-24 US disclosed
US-8524425-B2 Oxime ester photoinitiators BASF SE (DE) 2013-09-03 US disclosed
WO-2013038974-A1 COLORED RADIATION-SENSITIVE COMPOSITION FOR COLOR FILTER, PATTERN FORMING METHOD, COLOR FILTER AND METHOD OF PRODUCING THE SAME, AND SOLID-STATE IMAGE SENSOR FUJIFILM CORPORATION (JP) 2013-03-21 WO disclosed
US-20120077941-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS BRIDGESTONE CORPORATION (JP) 2012-03-29 US disclosed
US-8088868-B2 oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis BRIDGESTONE CORPORATION (JP) 2012-01-03 US disclosed
US-20100136467-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2010-06-03 US disclosed
US-20080146745-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS BRIDGESTONE CORPORATION (JP) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100136467-A1 OXIME ESTER PHOTOINITIATORS CHRM4, NR2E3, CYP3A4 HDAC3 926/4885HDAC1 2034/4885HDAC2 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.